Business

Neurizon Enters Global Licensing Agreement with Elanco

Neurizon Enters Global Licensing Agreement with Elanco

Neurizon Therapeutics LimitedJuly 1, 20255
Neurizon Enters Global Licensing Agreement with Elanco

About this update from Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Neurizon Therapeutics Limited

More from Neurizon Therapeutics Limited

All Neurizon Therapeutics Limited news →